Long-term follow-up is necessary to ensure that there are no late sequelae.

The case is an example of serious late sequelae of an occupational injury.

The role of anti-neuronal antibodies in late sequelae of OMA needs further clarification.

As a result, late sequelae of cancer and its treatment have become more common, particularly second malignancies.

Hence, better markers are required to restrict treatments causing late sequelae to those at highest risk of relapse.

The most intriguing late sequelae of chemotherapy were cardiomyopathy due to doxorubicin and hearing loss due to cisplatinum.

Using two different radiobiological models, we analyze the doses required to achieve equivalent disease control while reducing the severity of late sequelae.

Marginal failures have not been observed, supporting the use of limited margins to minimize late sequelae using stereotactic immobilization and planning techniques.

Although, for some endpoints, the incidence of late sequelae was higher than expected, overall morbidity was no worse than reported by others.

There was a significant correlation of late sequelae with lower stage disease (I and II) compared to more advanced disease (III and IV).